Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease
Authors:
- Kazushi NumataKNKazushi Numata
- Hiroyuki FukudaHFHiroyuki Fukuda
- Hiromi NihonmatsuHNHiromi Nihonmatsu
- Masaaki KondoMKMasaaki Kondo
- Akito NozakiANAkito Nozaki
- Makoto ChumaMCMakoto Chuma
- Manabu MorimotoMMManabu Morimoto
- Takashi OshimaTOTakashi Oshima
- Masahiro OkadaMOMasahiro Okada
- Takamichi MurakamiTMTakamichi Murakami
- Shigeo TakebayashiSTShigeo Takebayashi
- Shin MaedaShin Maeda
- 23 June 2015
- journal article
- Published by Springer Nature in Abdominal Radiology
- Vol. 40 (7) , 2372-2383
Abstract
We evaluated the use of tumor vessel patterns observed during arterial-phase contrast-enhanced ultrasonography (US) to differentiate regenerative nodules (RN) from early hepatocellular carcinoma (HCC) or high-grade dysplastic nodules (HGDN) in patients with chronic liver disease. Pathologically confirmed lesions (83 early HCC, 6 HGDN, and 13 RN with mean maximal diameters of 15.4, 15.3, and 16.2 mm, respectively) were enrolled in this retrospective study. We performed contrast-enhanced US using a perflubutane-based contrast agent. We then classified the tumor vessels observed during the arterial phase of contrast-enhanced US into two patterns: peripheral vessels (centripetal pattern) and central vessels (centrifugal pattern). Eighty-one (97.6%) of the 83 early HCC exhibited various enhancement patterns (hypovascular, 44.6%; isovascular, 25.3%; and hypervascular, 27.7%) and a peripheral vessel pattern, while the remaining 2 lesions (2.4%) exhibited hypovascular enhancement and a central vessel pattern. All 6 HGDN lesions were hypovascular with a peripheral vessel pattern. Twelve (92.3%) of the 13 RN were hypovascular with a central vessel pattern, and the remaining one (7.7%) was hypervascular with a central vessel pattern. When lesions exhibiting a central vessel pattern during arterial-phase contrast-enhanced US were diagnosed as RN, the sensitivity, specificity, and accuracy of these diagnoses were 100%, 97.8%, and 98.0%, respectively. The tumor vessel patterns observed during arterial-phase contrast-enhanced US may be useful for differentiating RN from early HCC or HGDN in patients with chronic liver disease.Keywords
This publication has 28 references indexed in Scilit:
- Epidemiology of Hepatocellular CarcinomaJournal of Clinical Gastroenterology, 2013
- Characterization of hepatic lesions (≤30mm) with liver-specific contrast agents: A comparison between ultrasound and magnetic resonance imagingEuropean Journal of Radiology, 2013
- Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imagingAbdominal Radiology, 2012
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasoundAbdominal Radiology, 2011
- Depiction of Portal Supply in Early Hepatocellular Carcinoma and Dysplastic Nodule: Value of Pure Arterial Ultrasound Imaging in Hepatocellular CarcinomaOncology, 2010
- Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia # †Hepatology, 2009
- Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosisCancer, 2005
- Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross typeHepatology Research, 2003
- Terminology of nodular hepatocellular lesionsHepatology, 1995